Richard Alvin on witnessing the devastation of the Altadena fires and why climate denial — from Trump to Clarkson — is a ...

Melrose CEO Peter Dilnot has overtaken AstraZeneca’s Pascal Soriot as the UK’s highest-paid FTSE 100 boss after a £45m payout ...

Pascal Soriot, who runs drugs giant AstraZeneca, has slipped to third place in our annual survey, after being replaced by the relatively unknown Dilnot.

So Sir Pascal may seem an unlikely ally of Donald Trump, who as America’s president has slashed public spending on scientific ...

Europe's pharmaceutical companies are bracing for United States President Donald Trump's plan to slap tariffs of up to 250 ...

The global trading system is adjusting to the tariffs levied by the United States: for most goods they look likely to settle ...

Today’s Forbes Daily newsletter covers Trump’s Fed chair candidates, Palantir’s rising share price, RFK cancels vaccine funding, GOP pushes for more on Epstein and more.

From tariffs to drug pricing to the FDA, biopharma CEOs find themselves pulled into policy discussions on this year’s second quarter earnings calls.

We will be totally self-sufficient for the supply of medicines to American patients.” AstraZeneca CEO Pascal Soriot on the company’s plan to invest $50 billion in the U.S.

Today’s Forbes CFO newsletter focuses on Aradhana Sarin’s journey from treating patients to becoming what she calls a ...